TBX1 and 22q11.2 deletion syndrome: Patient-derived iPSCs carrying congenital heart disease–associated mutations, including TBX1 haploinsufficiency as seen in DiGeorge syndrome, have been used to generate cardiac organoids capable of modeling aspects of disease-relevant phenotypes.